Mary Stenzel-Poore

Biography

Mary Stenzel-Poore is Professor and Interim Chair of the Department of Molecular Microbiology and Immunology at OHSU. She received her PhD in Immunology from Oregon Health and Sciences University (OHSU) in 1986. She was a postdoctoral fellow at the Salk Institute in San Diego prior to joining the Department of Molecular Microbiology and Immunology (MMI) at OHSU as an Assistant Professor in 1995. She was appointed interim chair of MMI in 2008.

Key Publications

Stenzel-Poore MP, Stevens SL, Xiong Z, Lessov NS, Harrington CA, Mori M, Meller R, Rosenzweig HL, Tobar E, Shaw TE, Chu X, and Simon RP. (2003) Effects of Ischemic preconditioning on genomic response to cerebral ischemia: similarity to  neuroprotective strategies in hibernation and hypoxia-tolerant states. The Lancet 362:1028-1037. PMID:14522533.

Marsh BJ, and Stenzel-Poore MP. (2008) Toll-like receptors: novel pharmacological targets for the treatment of neurological diseases. Current Opinion in Pharmacology, 8:8-13.  PMID:17974478.

Stevens SL, Ciesielski TM, Marsh BJ, Yang T, Homen DS, Boule JL, Lessov NS, Simon RP, and Stenzel-Poore MP. (2008) Toll-like receptor 9: A new target of ischemic preconditioning in the brain. J Cereb Blood Flow Metab, 28(5): 1040-1047. PMID:18183029.

Marsh B, Stevens SL, Packard AE, Gopalan B, Hunter B, Leung PY, Harrington CA, and Stenzel-Poore MP.  (2009) Systemic lipopolysaccharide protects the brain from ischemic injury by reprogramming the response of the brain to stroke: a critical role for IRF3.  J. Neuroscience  29:9839-9849.  PMID:19657036.